Microfluidic Device Rapidly Detects Urinary Tract Infections
By LabMedica International staff writers Posted on 23 Aug 2015 |

Image: The workflow of the Lab-on-a-Disc device for identifying bacteria in urine samples. From left to right (i) Urine sample from patient; (ii) Capturing bacteria in V-cup-structures on a Lab-on-a-Disk platform by centrifugation; (iii) Raman spectroscopic analysis of captured bacteria within the V-cups; (iv) Fingerprint-like spectroscopic information on the UTI pathogen (Photo courtesy of Ute Neugebauer).

Image: The alpha300 R Superior Confocal Raman Imaging System (Photo courtesy of WITec).
A polymeric centrifugal microfluidic platform has been developed for the rapid and sensitive identification of bacteria directly from urine, thus eliminating time-consuming cultivation steps.
Untreated urinary tract infections can quickly move to a life-threatening condition and cases may trigger sepsis, which occurs when the immune system, in an attempt to fight off the infection, inadvertently activates body-wide inflammation that can cause blood clots and leaky blood vessels.
Scientists at the Jena University Hospital (Germany) have created a Lab-on-a-Disc platform that combines microfluidics and Raman microscopy, a modern optical detection method. The platform utilizes the rotationally induced centrifugal field to efficiently capture bacteria directly from suspension within a glass-polymer hybrid chip. Once trapped in an array of small V-shaped structures, the bacteria are readily available for spectroscopic characterization, such as Raman spectroscopic fingerprinting, providing valuable information on the characteristics of the captured bacteria.
Anonymized urine samples were provided by the hospital’s Institute of Medical Microbiology. They originated from different patients with single pathogen urinary tract infections (UTIs) of Enterococcus faecalis and Escherichia coli. To remove bigger particles such as leukocytes or epithelial cells, the urine samples were run through membrane filters, centrifuged, the pellet washed twice with phosphate buffered saline (PBS), and is finally re-suspended in PBS before being loaded into the device. A CRM 300 micro-Raman setup (WITec, Ulm, Germany), equipped with a 600 lines/mm grating was used for micro-Raman measurements.
The whole procedure, including sample preparation, requires about one hour to obtain a valuable result, marking a significant reduction in diagnosis time when compared to the 24 hours and more, typically required for standard microbiological methods. Characterization of the captured bacteria by label-free conventional micro-Raman spectroscopy allows rapid identification of the pathogens with their characteristic features, which is valuable for first screening analysis. The device has been easily adapted for fluorescence measurements, paving the way for the development of microfluidics-based immunochemical assays, illustrating a high potential of the device for numerous applications in spectroscopy-based point-of-care diagnostics.
Ulrich-Christian Schröder, a doctoral student and lead author of the study said, “Our device works by loading a few microliters of a patient's urine sample into a tiny chip, which is then rotated with a high angular velocity so that any bacteria is guided by centrifugal force through microfluidic channels to a small chamber where 'V-cup capture units' collect it for optical investigation. We were able to identify Escherichia coli and Enterococcus faecalis within 70 minutes, directly from patients' urine samples.” The study was published on August 11, 2015, in the journal Biomicrofluidics.
Related Links:
Jena University Hospital
WITec
Untreated urinary tract infections can quickly move to a life-threatening condition and cases may trigger sepsis, which occurs when the immune system, in an attempt to fight off the infection, inadvertently activates body-wide inflammation that can cause blood clots and leaky blood vessels.
Scientists at the Jena University Hospital (Germany) have created a Lab-on-a-Disc platform that combines microfluidics and Raman microscopy, a modern optical detection method. The platform utilizes the rotationally induced centrifugal field to efficiently capture bacteria directly from suspension within a glass-polymer hybrid chip. Once trapped in an array of small V-shaped structures, the bacteria are readily available for spectroscopic characterization, such as Raman spectroscopic fingerprinting, providing valuable information on the characteristics of the captured bacteria.
Anonymized urine samples were provided by the hospital’s Institute of Medical Microbiology. They originated from different patients with single pathogen urinary tract infections (UTIs) of Enterococcus faecalis and Escherichia coli. To remove bigger particles such as leukocytes or epithelial cells, the urine samples were run through membrane filters, centrifuged, the pellet washed twice with phosphate buffered saline (PBS), and is finally re-suspended in PBS before being loaded into the device. A CRM 300 micro-Raman setup (WITec, Ulm, Germany), equipped with a 600 lines/mm grating was used for micro-Raman measurements.
The whole procedure, including sample preparation, requires about one hour to obtain a valuable result, marking a significant reduction in diagnosis time when compared to the 24 hours and more, typically required for standard microbiological methods. Characterization of the captured bacteria by label-free conventional micro-Raman spectroscopy allows rapid identification of the pathogens with their characteristic features, which is valuable for first screening analysis. The device has been easily adapted for fluorescence measurements, paving the way for the development of microfluidics-based immunochemical assays, illustrating a high potential of the device for numerous applications in spectroscopy-based point-of-care diagnostics.
Ulrich-Christian Schröder, a doctoral student and lead author of the study said, “Our device works by loading a few microliters of a patient's urine sample into a tiny chip, which is then rotated with a high angular velocity so that any bacteria is guided by centrifugal force through microfluidic channels to a small chamber where 'V-cup capture units' collect it for optical investigation. We were able to identify Escherichia coli and Enterococcus faecalis within 70 minutes, directly from patients' urine samples.” The study was published on August 11, 2015, in the journal Biomicrofluidics.
Related Links:
Jena University Hospital
WITec
Latest Microbiology News
- Viral Load Tests Can Help Predict Mpox Severity
- Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
- Credit Card-Sized Test Boosts TB Detection in HIV Hotspots
- Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients
- Portable Molecular POC System Rules Out UTIs in Just 35 Minutes
- POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques
- Rapid Diagnostic Test Slashes Sepsis Mortality by 39%
- Blood Culture Assay Enhances Diagnostic Stewardship Through Targeted Panel Selection
- Real-Time Genome Sequencing Detects Dangerous Superbug Causing Hospital Infections
- Diagnostic Test Accurately Detects Colorectal Cancer by Identifying Microbial Signature in Gut Bacteria
- Rapid Bedside Test Predicts Sepsis with Over 90% Accuracy
- New Blood Test Detects Up to Five Infectious Diseases at POC
- Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
- New Test Diagnoses Bacterial Meningitis Quickly and Accurately
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Channels
Clinical Chemistry
view channel
New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
A new clinical chemistry analyzer is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories.... Read more
New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read moreMolecular Diagnostics
view channel
Newly-Cleared Technology a Game Changer for Diagnosis of Lyme Disease
Lyme disease is one of the fastest-growing infectious diseases, with approximately 476,000 cases diagnosed annually in the United States. The symptoms of Lyme disease, such as fever, headache, fatigue,... Read more
Innovative Liquid Biopsy Test Uses RNA to Detect Early-Stage Cancer
Detecting and diagnosing cancer, particularly in its early stages, remains a significant challenge. Liquid biopsies offer a promising non-invasive alternative to traditional biopsies, which require removing... Read moreHematology
view channel
Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read moreImmunology
view channel
World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment
Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Blood Test Detects Organ Rejection in Heart Transplant Patients
Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer
Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more
Computational Tool Exposes Hidden Cancer DNA Changes Influencing Treatment Resistance
Structural changes in tumor DNA are among the most damaging genetic alterations in cancer, yet they often go undetected, particularly when tissue samples are degraded or of low quality. These hidden genomic... Read moreMicrobiology
view channel
Viral Load Tests Can Help Predict Mpox Severity
Mpox is a viral infection that causes flu-like symptoms and a characteristic rash, which evolves significantly over time and varies between patients. The disease spreads mainly through direct contact with... Read more
Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes
Gestational diabetes mellitus is a common metabolic disorder marked by abnormal glucose metabolism during pregnancy, typically emerging in the mid to late stages. It significantly heightens the risk of... Read morePathology
view channel
AI Tool Enhances Interpretation of Tissue Samples by Pathologists
Malignant melanoma, a form of skin cancer, is diagnosed by pathologists based on tissue samples. A crucial aspect of this process is estimating the presence of tumor-infiltrating lymphocytes (TILs), immune... Read more
AI-Assisted Technique Tracks Cells Damaged from Injury, Aging and Disease
Senescent cells, which stop growing and reproducing due to injury, aging, or disease, play a critical role in wound repair and aging-related diseases like cancer and heart disease. These cells, however,... Read more
Novel Fluorescent Probe Shows Potential in Precision Cancer Diagnostics and Fluorescence-Guided Surgery
Hepatocellular carcinoma (HCC), a common type of liver cancer, is difficult to diagnose early and accurately due to the limitations of current diagnostic methods. Glycans, carbohydrate structures present... Read moreIndustry
view channel
Quanterix Completes Acquisition of Akoya Biosciences
Quanterix Corporation (Billerica, MA, USA) has completed its previously announced acquisition of Akoya Biosciences (Marlborough, MA, USA), paving the way for the creation of the first integrated solution... Read more
Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis
Lunit (Seoul, South Korea) and Microsoft (Redmond, WA, USA) have entered into a collaboration to accelerate the delivery of artificial intelligence (AI)-powered healthcare solutions. In conjunction with... Read more